Author Archives: Ryan Tantalo

From Constitutional Attack to Statutory Combat: The Next Wave of Medicare Drug-Price Litigation

By: Jimmie L. Bullock  Background  On May 18, 2026, the Supreme Court declined to review six pharmaceutical manufacturers’ challenges to the Medicare Drug Price Negotiation Program (MDPNP). For nearly three years, manufacturers had… Read more »

Access to Mifepristone Across the United States: An Issue of State Abortion Access or Federal Drug Regulation?

Written by: Jessie Litwin On May 1, 2026, the Fifth Circuit Court of Appeals issued a decision—after the state of Louisiana challenged the Food and Drug Administration (FDA)—that reimposed the… Read more »

Legal Challenges Continue Against Social Media Companies for Alleged Role in the Youth Mental Health Crisis

Written by: Liz Hughes In recent months, social media companies have faced increasing legal pressure over their alleged responsibility for the mental health crisis affecting young users. In May 2026,… Read more »